Creso Pharma Limited Performance
| COPHFDelisted Stock | USD 0.12 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Creso Pharma are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Creso Pharma Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Creso Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 6 M | |
| Total Cashflows From Investing Activities | -1.4 M |
Creso |
Creso Pharma Relative Risk vs. Return Landscape
If you would invest 12.00 in Creso Pharma Limited on September 16, 2024 and sell it today you would earn a total of 0.00 from holding Creso Pharma Limited or generate 0.0% return on investment over 90 days. Creso Pharma Limited is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Creso, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Creso Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Creso Pharma's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Creso Pharma Limited, and traders can use it to determine the average amount a Creso Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| COPHF |
Based on monthly moving average Creso Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Creso Pharma by adding Creso Pharma to a well-diversified portfolio.
Creso Pharma Fundamentals Growth
Creso Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Creso Pharma, and Creso Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Creso Pink Sheet performance.
| Return On Equity | -0.67 | |||
| Return On Asset | -0.38 | |||
| Profit Margin | (2.41) % | |||
| Operating Margin | (2.39) % | |||
| Current Valuation | 24.06 M | |||
| Shares Outstanding | 2 B | |||
| Price To Book | 0.36 X | |||
| Price To Sales | 4.68 X | |||
| Revenue | 6.22 M | |||
| EBITDA | (28.06 M) | |||
| Cash And Equivalents | 3.14 M | |||
| Total Debt | 3.26 M | |||
| Debt To Equity | 0.24 % | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (22.38 M) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 29.31 M | |||
About Creso Pharma Performance
By analyzing Creso Pharma's fundamental ratios, stakeholders can gain valuable insights into Creso Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Creso Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Creso Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia. Creso Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Things to note about Creso Pharma Limited performance evaluation
Checking the ongoing alerts about Creso Pharma for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Creso Pharma Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Creso Pharma Limited is not yet fully synchronised with the market data | |
| Creso Pharma Limited generated a negative expected return over the last 90 days | |
| Creso Pharma Limited has some characteristics of a very speculative penny stock | |
| Creso Pharma Limited has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 6.22 M. Net Loss for the year was (30.03 M) with loss before overhead, payroll, taxes, and interest of (400.39 K). | |
| Creso Pharma Limited has accumulated about 3.14 M in cash with (22.38 M) of positive cash flow from operations. | |
| Roughly 27.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Recursion Pharmaceuticals Shares Gap Up Time to Buy |
- Analyzing Creso Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Creso Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Creso Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Creso Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Creso Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Creso Pharma's pink sheet. These opinions can provide insight into Creso Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Creso Pink Sheet
If you are still planning to invest in Creso Pharma Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Creso Pharma's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |